Valuation: Terumo Corporation

Market Cap 3,500B 22.2B 19.2B 17.93B 16.45B 30.94B 2,112B 31.43B 210B 82.57B 1,059B 83.35B 81.53B P/E 2027 *
19.2x
P/E 2028 * 18.5x
Enterprise Value 3,560B 22.57B 19.52B 18.23B 16.73B 31.46B 2,148B 31.96B 214B 83.96B 1,077B 84.76B 82.91B EV / Sales 2027 *
2.85x
EV / Sales 2028 * 2.6x
Free-Float
97.07%
Yield 2027 *
1.52%
Yield 2028 * 1.7%
1 day+2.64%
1 week+2.11%
Current month+2.11%
1 month+2.11%
3 months+21.26%
6 months+16.04%
Current year+4.54%
1 week 2,255
Extreme 2255
2,376.5
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.64%+2.11%-6.21%+6.72% 22.2B
-0.14%+2.00%-18.36%-0.59% 187B
+1.44%+2.07%-4.47%+2.88% 112B
-1.40%+2.93%+15.11%+71.75% 61.15B
+0.65%+3.91%+37.08%+53.44% 54.39B
-0.12%+6.79%-5.77%-35.74% 48.17B
+2.08%+1.56%+10.93%-29.94% 31.98B
+2.09%-10.31% - - 30.91B
+1.57%+3.85%+47.20%-6.50% 24.92B
+2.45%+3.97%+0.52%+4.99% 23.14B
Average +1.13%+1.52%+8.45%+7.45% 59.5B
Weighted average by Cap. +0.61%+2.02%+0.24%+8.74%

Financials

2027 *2028 *
Net sales 1,251B 7.93B 6.86B 6.41B 5.88B 11.05B 755B 11.23B 75.17B 29.5B 378B 29.78B 29.13B 1,330B 8.44B 7.3B 6.81B 6.25B 11.76B 803B 11.95B 79.96B 31.38B 402B 31.68B 30.99B
Net income 184B 1.17B 1.01B 942M 864M 1.63B 111B 1.65B 11.05B 4.34B 55.63B 4.38B 4.28B 188B 1.19B 1.03B 964M 884M 1.66B 114B 1.69B 11.31B 4.44B 56.91B 4.48B 4.38B
Net Debt 59.15B 375M 324M 303M 278M 523M 35.7B 531M 3.55B 1.4B 17.89B 1.41B 1.38B -37.24B -236M -204M -191M -175M -329M -22.47B -334M -2.24B -878M -11.26B -887M -867M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
07/08/26 JP¥2,373.00 +2.64% 4,340,100
06/08/26 JP¥2,312.00 +1.05% 4,737,000
05/08/26 JP¥2,288.00 -1.51% 4,036,400
04/08/26 JP¥2,323.00 +0.50% 2,875,800
03/08/26 JP¥2,311.50 -0.54% 3,619,300
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,373.00JPY
Average target price
3,067.69JPY
Spread / Average Target
+29.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock